Loading ...
Sorry, an error occurred while loading the content.

Fwd: NORML News of the Week 12/1/2011

Expand Messages
  • rebelljb@aol.com
    ... From: NORML News To: NORML News Sent: Thu, Dec 1, 2011 10:17 pm Subject: NORML News of the Week 12/1/2011
    Message 1 of 1 , Dec 1, 2011
    • 0 Attachment
      -----Original Message-----
      From: NORML News <letters@...>
      To: NORML News <norml_news@...>
      Sent: Thu, Dec 1, 2011 10:17 pm
      Subject: NORML News of the Week 12/1/2011


      To unsubscribe, follow the instructions at the bottom.



      Volume 14 Issue 47
      12/01/2011




      HomeAbout NORMLAbout MarijuanaState InfoLegal IssuesLibraryNews
      ReleasesBlogAudio/VideoSupport




      From NORML.org:
      Cannabis Beneficial To Patients With Inflammatory Bowel Disease
      Prescription Drug Efavirenz Yields False Positive Test Results For THC,
      Study Says
      Hospice Health Professionals Support Legalization Of Cannabis For
      Therapeutic Use
      Recent Action Alerts:
      Tell The Obama Administration to Halt Its Attack on Medical Marijuana
      Tell Your Representatives to Co-Sponsor HR 2306: The Ending Federal
      Marijuana Prohibition Act of 2011
      Massachusetts Legislature Considers Medical Marijuana Measure

      ------------------------------------------------------------

      Cannabis Beneficial To Patients With Inflammatory Bowel Disease

      "Inhaled cannabis improves quality of life measurements, disease
      activity index, and causes weight gain"
      Tel Aviv, Israel: The inhalation of cannabis increases quality of life,
      mitigates disease activity, and promotes weight gain in subjects with
      inflammatory bowel disease (IBD), according to clinical trial data
      published online in the scientific journal Digestion.
      Investigators at the Chaim Sheba Medical Center in Tel Aviv, Israel
      assessed the efficacy of inhaled prescription cannabis in patients with
      long-standing IBD, such as Crohn's disease.
      Researchers reported: "After three months' treatment, patients reported
      improvement in general health perception, social functioning, ability
      to work, physical pain and depression. A schematic scale of health
      perception showed an improved score. ... Patients had ... weight gain
      ... during treatment and an average rise in BMI (body mass index)."
      They concluded, "Three months' treatment with inhaled cannabis improves
      quality of life measurements, disease activity index, and causes weight
      gain and rise in BMI in long-standing IBD patients."
      An estimated 6,000 Israelis are supplied with locally grown cannabis
      for therapeutic purposes as part of a limited government program.
      Survey data published in August in the European Journal of
      Gastroenterology and Hepatology reported that an estimated one-third of
      patients with colitis and one-half of subjects with Crohn's acknowledge
      having used cannabis to mitigate their disease symptoms.
      Most recently, clinical trial data published in September in the
      Journal of the Israeli Medical Association reported that the use of
      cannabis is associated with a reduction in Crohn's disease activity and
      disease-related surgeries.
      Researchers at the Meir Medical Center in Israel are presently
      evaluating the safety and efficacy of inhaled cannabis for patients
      with Crohn's and Ulcerative Colitis in a double-blind,
      placebo-controlled trial, according to a summary of the US federal
      government website clinicaltrials.gov.
      For more information, please contact Paul Armentano, NORML Deputy
      Director, at paul@.... Full text of the study, "Impact of
      Cannabis Treatment on the Quality of Life, Weight and Clinical Disease
      Activity in Inflammatory Bowel Disease Patients: A Pilot Prospective
      Study," appears in Digestion.
      --- You are currently subscribed to norml_news as: rebelljb@... To
      unsubscribe send a blank email to media@....

      Prescription Drug Efavirenz Yields False Positive Test Results For THC,
      Study Says

      Pretoria, South Africa: Prescription doses of the antiretroviral
      prescription drug efavirenz (EFV) cross-reacts in urine immunoassay
      tests for the carboxy THC metabolite, according to clinical data
      published online in the journal Annals of Clinical Biochemistry.
      Investigators at the University of Pretoria in South Africa analyzed
      random urine samples from 30 patients on EFV therapy for THC
      metabolites by two near-testing devices (THC One Step Marijuana and
      Rapid Response(®) Drugs of Abuse Test Strips) and two automated
      immunoassays (Roche Diagnostics Cannabinoids II and Beckman Coulter
      SYNCHRON(®) Systems THC2). THC confirmatory testing was performed by
      gas chromatography-mass spectrometry (GC-MS).
      Authors reported: "GC-MS failed to detect THC metabolites in any of the
      samples, as did three of the four immunoassays. However, the Rapid
      Response(®) test strips yielded positive results in 28 out of 30
      samples."
      Separate studies have previously documented that efavirenz may yield
      so-called 'false positive' test results for the carboxy THC metabolite
      on various types of presumptive immunoassay urine tests.
      For more information, please contact Paul Armentano, NORML Deputy
      Director, at: paul@.... Full text of the study, "Efavirenz
      interference in urine screening immunoassays for tetrahydrocannabinol,"
      appears in Annals of Clinical Biochemistry.
      --- You are currently subscribed to norml_news as: rebelljb@... To
      unsubscribe send a blank email to media@....

      Hospice Health Professionals Support Legalization Of Cannabis For
      Therapeutic Use

      Philadelphia, PA: A majority of hospice health professionals favor
      allowing the legally regulated use of cannabis for terminally ill
      patients, according to survey data published online in the Journal of
      Palliative Medicine.
      Investigators at the University of Pennsylvania utilized a 16-item
      questionnaire to assess the knowledge, experience, and views of hospice
      professionals regarding the use of marijuana in terminally ill patients.
      Authors concluded, "The study results revealed that, like the general
      public, hospice health care providers are generally in favor of
      legalization of marijuana and, if legalized, would support its use in
      symptom management for their terminally ill patients."
      Various health professional organizations, including the American
      Nurses Association and the American Public Health Association, have
      enacted resolutions in support of allowing patients the legal
      alternative to use cannabis therapy.
      For more information, please contact Paul Armentano, NORML Deputy
      Director, at: paul@.... Full text of the study, "Assessment of
      hospice health professional knowledge, views, and experience with
      medical marijuana," appears in the Journal of Palliative Medicine. ---
      You are currently subscribed to norml_news as: rebelljb@... To
      unsubscribe send a blank email to media@....


      NORML and the NORML Foundation: 1600 K Street NW, Mezzanine Level,
      Washington DC, 20006-2832
      Tel: (202) 483-5500 • Fax: (202) 483-0057 • Email: norml@...






      End Marijuana Prohibition





      Breaking News: Two Governors Petition Federal Government To Allow For
      Medical Marijuana Details
      11/30/11 6:45pm EST
      Want to Lower Traffic Fatalities? Try Legalizing Medical Marijuana.
      Details
      11/29/11 3:57pm EST
      Go “Green” on Cyber Monday Details
      11/28/11 11:38am EST
      Current TV: Marijuana Prohibition In America Examined Tonight Details
      11/28/11 10:45am EST
      HIGH TIMES Cannabis Cup Raided in Amsterdam Details
      11/23/11 3:25pm EST




      Support Marijuana Law Reform



      Cannabis and Driving



      NORML Women's Alliance




      Emerging Clinical
      Applications for Cannabis
      and Cannabinoids



      NORML Videos


      More Info From NORML

      About Marijuana
      State Laws
      FAQ's
      Personal Use
      Medical Use
      Industrial Use
      Legal Issues
      Find A Lawyer
      NORML in the Media



      Other Ways to Help
      Join NORML
      Tell Congress
      Cafe Press Gear
      Direct from NORML



      Networking
      Facebook
      Twitter
      YouTube
      Flickr
      Tumblr





      --- You are currently subscribed to norml_news as: rebelljb@... To
      unsubscribe send a blank email to media@....
    Your message has been successfully submitted and would be delivered to recipients shortly.